Q3 2025 Mirion Technologies Inc Earnings Call Transcript
Key Points
- Mirion Technologies Inc (MIR) reported strong third quarter results with revenue totaling $223 million, an 8% increase from the previous year.
- The nuclear power market continues to be a significant growth driver, with organic revenue growing 9% in the quarter and 11% year-to-date.
- Adjusted EBITDA increased by 14.7% to $52.4 million, with both the nuclear and safety and medical segments contributing to margin expansion.
- The company successfully reduced its blended cost of debt to 2.8%, reflecting a 460 basis points improvement over the past year.
- Mirion Technologies Inc (MIR) raised the low end of its adjusted free cash flow guidance for 2025 to between $100 million and $115 million, indicating strong cash flow performance.
- The US healthcare environment is pressuring the RTQA business, with uncertainties around the timing and magnitude of a rebound due to government shutdown headwinds.
- Demand from the US Department of Energy has been muted, impacting the labs and research market.
- The medical segment faced a decline in adjusted orders by $4.7 million, primarily due to challenges in the RTQA market.
- The company noted a slowdown in order flow from China for laboratory instruments, which is seen as a transitory dynamic.
- Despite strong performance, the timing of large project awards remains unpredictable, particularly those impacted by government funding dynamics.
Greetings and welcome to the Mirion Technologies third quarter 2025 earnings conference call. (Operator Instructions)
It is now my pleasure to introduce your host, Eric Linn, treasurer and head of investor relations.
Thank you. You may begin.
Thank you. Good morning and welcome to Mirion's third quarter, 2025 earnings conference call.
Joining me this morning are Mirion's founder, Chairman and CEO Tom Logan, and Marion's CFO and Medical Group President, Brian Schopfer.
Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward-looking statements, and actual results may differ materially from those projected in the forward-looking statements.
The factors that could cause actual results to differ are discussed in our annual reports on Form 10-K, quarterly reports on Form 10-Q, and in myriad's other SEC filings under the caption risk factors.
Quarterly references within today's discussion
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
